Thrivent Financial for Lutherans raised its stake in shares of RXO, Inc. (NYSE:RXO – Free Report) by 10.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 107,817 shares of the company’s stock after buying an additional 10,235 shares during the period. Thrivent Financial for Lutherans owned 0.07% of RXO worth $3,019,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently made changes to their positions in the company. GAMMA Investing LLC grew its holdings in RXO by 40.0% in the 3rd quarter. GAMMA Investing LLC now owns 1,784 shares of the company’s stock valued at $50,000 after buying an additional 510 shares during the last quarter. KBC Group NV boosted its position in shares of RXO by 28.1% in the third quarter. KBC Group NV now owns 4,055 shares of the company’s stock valued at $114,000 after acquiring an additional 890 shares during the period. Canada Pension Plan Investment Board bought a new stake in shares of RXO in the second quarter valued at approximately $112,000. City Holding Co. grew its stake in shares of RXO by 57.9% in the third quarter. City Holding Co. now owns 5,241 shares of the company’s stock worth $147,000 after acquiring an additional 1,921 shares during the last quarter. Finally, Quintet Private Bank Europe S.A. increased its position in RXO by 29.6% during the third quarter. Quintet Private Bank Europe S.A. now owns 5,304 shares of the company’s stock worth $149,000 after acquiring an additional 1,212 shares during the period. Institutional investors and hedge funds own 92.73% of the company’s stock.
RXO Price Performance
Shares of RXO opened at $30.88 on Wednesday. The company has a quick ratio of 1.33, a current ratio of 1.33 and a debt-to-equity ratio of 0.21. The stock has a market cap of $4.97 billion, a PE ratio of -15.60, a PEG ratio of 15.28 and a beta of 1.33. RXO, Inc. has a 12-month low of $18.75 and a 12-month high of $32.82. The business has a 50-day simple moving average of $28.11 and a two-hundred day simple moving average of $26.47.
Analyst Ratings Changes
Several research analysts have recently issued reports on RXO shares. Susquehanna dropped their price objective on shares of RXO from $16.00 to $12.00 and set a “negative” rating on the stock in a report on Tuesday, November 12th. Oppenheimer restated an “outperform” rating and set a $31.00 price target on shares of RXO in a research note on Tuesday, September 17th. The Goldman Sachs Group reiterated a “neutral” rating and issued a $29.00 price objective on shares of RXO in a research report on Monday, November 18th. Citigroup lowered RXO from a “buy” rating to a “neutral” rating and set a $33.00 price objective on the stock. in a report on Tuesday, November 12th. Finally, UBS Group upped their target price on RXO from $22.00 to $31.00 and gave the company a “neutral” rating in a research note on Thursday, August 8th. Two analysts have rated the stock with a sell rating, twelve have assigned a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $26.47.
Check Out Our Latest Report on RXO
RXO Company Profile
RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.
See Also
- Five stocks we like better than RXO
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- Technology Stocks Explained: Here’s What to Know About Tech
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- About the Markup Calculator
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.